FIELD: medicine, oncology. SUBSTANCE: before patient treatment lymphocytes are taken from blood and incubated with fetal protein. Amount of T-supressor/cytotoxic (CD8+) lymphocytes and T-helper/inductive (CD4+) lymphocytes are determined. Positive effect of fetal therapy in oncological patients is prognosticated if amount of (CD8+)-lymphocytes exceeds amount of (CD4+)-lymphocytes by 15% and above. Method ensures to prognosticated effectiveness of fetal therapy in vitro before patients treatment onset. EFFECT: improved method of prognosis of fetal therapy. 1 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD OF ASSAY OF ACTIVITY OF PATHOLOGICAL PROCESS IN PATIENTS WITH CEREBROSPINAL SCLEROSIS | 1997 |
|
RU2116651C1 |
METHOD FOR PLATELET AUTOANTIBODY TEST | 2012 |
|
RU2488114C1 |
METHOD FOR TREATING MALIGNANT TUMORS | 1995 |
|
RU2105567C1 |
METHOD FOR TREATING CHILDREN FOR AUTOIMMUNE THYROIDITIS | 2002 |
|
RU2221535C1 |
METHOD FOR PREVENTING POSTOPERATIVE COMPLICATIONS IN IMPLANTING ARTIFICIAL EYE LENS | 1997 |
|
RU2164395C2 |
METHOD FOR IMMUNOTHERAPY OF CHRONIC REFRACTORY HERPES VIRUS INFECTION | 2011 |
|
RU2485962C1 |
METHOD FOR IMMUNOCORRECTION OF CHRONIC OBSTRUCTIVE BRONCHITIS | 2007 |
|
RU2347588C1 |
IMMUNOMODULATING SELENIUM-CONTAINING PHOSPHOLIPOGLYCOPROTEIN ORGANOELEMENTAL AGENT AND METHOD OF IMMUNOMODULATION | 2000 |
|
RU2167652C1 |
METHOD FOR IDENTIFYING ANTIGEN/HAPTEN-SPECIFIC IMMUNOCOMPETENT BLOOD CELLS SUBPOPULATIONS | 1997 |
|
RU2128841C1 |
METHOD FOR SCREENING MALIGNANT NEOPLASMS IN HUMANS | 2017 |
|
RU2665965C1 |
Authors
Dates
1998-09-10—Published
1996-02-01—Filed